Back to News
Market Impact: 0.05
Avicanna to Present at the Life Sciences Investor Forum on Sep 17th
Source: GlobeNewswire
Healthcare & Biotech
The company invited life-sciences investors, advisors and analysts to attend live interactive presentations through VirtualInvestorConferences.com. The announcement provides no financial results, operating updates, guidance, or other material corporate developments.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
neutral
Sentiment Score
0.00
More News
- Wells Fargo sees improvement in a key metric — plus, Lilly gets praise beyond GLP-1s
- Hong Kong unveils first five-year plan to add jobs, homes, align closer to mainland China
- Beta Bionics prices $150M public offering at $17.25/share
- Inside South Korea’s university programs offering a direct route to Samsung and SK Hynix
- A sharp stock market decline could lie around the corner, Wells Fargo warns
- Why is Vera Therapeutics stock reversing its premarket gains?